Home › Peripheral Arterial Disease › NCT06263322
The ROAMM-EHR Study
ROAMM-EHR: Pilot Trial of a Real-Time Symptom Surveillance System for Post-Discharge Surgical Patients
Who can join
Ages 60 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * age \>= 60; Patients with chronic limb threatening ischemia who are undergoing re-vascular surgery \[endovascular or open re-vascularization (bypass)\]. Exclusion Criteria: * High risk of post-surgical amputation based on study physician judgement, non-english speaker, diagnosis of an age-related dementia (e.g. Alzheimer's Disease); unable to communicate because of severe hearing loss; uncorrectable vision impairment that compromises clinical assessments or would cause a safety concern, other significant co-morbid disease that in the opinion of the investigators and study physician would impair the ability to participate in the study or be a safety concern
About the study
In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD) from older patients undergoing bypass surgery due to chronic limb threatening ischemia. The hypothesis is that integrating PGHD with an EHR system will help providers manage post-surgical symptoms and thus improve post-operative mobility and quality of life health outcomes.
What is being tested
- Actionable remotely generated health data (behavioral)
- Non-Actionable remotely generated health data (behavioral)
Sponsor: University of Florida · Participants: 50 · Started: Nov 16, 2023
Contact the study team
- Institute_on_Aging · Phone: 352-273-5919
- HOBI department · Phone: (352) 627-9467
Official record on ClinicalTrials.gov — NCT06263322
Locations in the U.S.
| Florida | Institute of Aging, Gainesville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.